Atlas Trials

Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

Clinical trial NCT01701479 · UNKNOWN

Trial details

NCT number
NCT01701479
Sponsor
St. Anna Kinderkrebsforschung
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2012-01-01
Primary completion
2020-12-01
Enrollment
288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.